The Global Heart-lung Machine Market, valued at approximately USD 2.18 billion in 2022, is projected to grow at a robust CAGR of more than 6.9% during the forecast period from 2023 to 2030. Read the ...
A home-based exercise program boosted exercise capacity and quality of life among patients after lung cancer surgery but did not improve self-reported physical function, a new study found.
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 gets EMA PRIME designation in relapsed extensive-stage small-cell lung cancer: London Saturday, December 21, 2024, 17:30 ...